Learn more

ENDORECH INC

Overview
  • Total Patents
    388
  • GoodIP Patent Rank
    144,734
About

ENDORECH INC has a total of 388 patent applications. Its first patent ever was published in 1990. It filed its patents most often in United States, China and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and machines are STEGRAM PHARMACEUTICALS LTD, REPROS THERAPEUTICS INC and UMECRINE COGNITION AB.

Patent filings per year

Chart showing ENDORECH INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Labrie Fernand 306
#2 Gauthier Sylvain 42
#3 Merand Yves 37
#4 Fernand Labrie 31
#5 Singh Shankar Mohan 29
#6 Breton Rock 27
#7 El-Alfy Mohamed 26
#8 Luu-The Van 20
#9 Berger Louise 17
#10 Provencher Louis 15

Latest patents

Publication Filing date Title
AU2014274607A1 Helix 12 directed steroidal pharmaceutical products
WO2011156908A1 Methods of treating or preventing estrogen-related diseases
US2010317635A1 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
UA100701C2 Dhea composition for pausimenia treatment
BRPI0703735A2 improvement in optically active compound or pharmaceutically acceptable salt thereof and composition containing said compound
AU2006230652A1 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
UA97786C2 Helix 12 directed non-steroidal antiandrogens
US2006287327A1 Helix 12 directed non-steroidal antiandrogens
AU2006201900A1 Selective estrogen receptor modulators in combination with estrogens
WO2005066194A1 Helix 12 directed steroidal pharmaceutical products
US2004224935A1 Topical antiandrogenic steroids
AU2004200178A1 Pharmaceutical Compositions and Uses for Androst-5-ene-3B,17B-diol
AU2004200173A1 Inhibitors of Type 5 and Type 3 17B-Hydroxysteroid Dehydrogenase and Methods for Their Use
AU2004200099A1 Medical Uses of A Selective Estrogen Receptor Modulator in Combination with Sex Steroid Precursors
EP1474127A1 Biphenyl derivatives and their use as antiandrogenic agents
IL150767D0 Benzopyran-containing compounds and their use in manufacture of medicament for treatment of estrogen sensitive diseases such as endometrial cancer
AU5990701A Isolated DNA sequence encoding type 5 17beta-hydroxysteroid dehydrogenase
TWI293251B Selective estrogen receptor modulators incombination with estrogens
IL149990D0 Selective estrogen receptor modulators in combination with estrogens
AU7896100A Selective estrogen receptor modulators in the treatment or reduction of the riskof acquiring hypertension, cardiovascular diseases, and insulin resistance